1 min read

Why Privacy Changes Demand a Better Approach to Targeting: Real World Data

Featured Image

By: Emilie Branch, Content Manager, Swoop 

Building custom audience segments can help marketers better reach consumers.

Katie Carr, SVP of sales at Swoop, explains how pharma brands can leverage condition-specific patient segments to connect with more relevant consumer audiences online. Carr delves into the privacy changes being made by branded technology walled gardens and why strengthening targeting via a custom-built patient audience segment puts advertisers in a more favorable position as those shifts occur.

 


About the Author

Emilie Branch 

Content Manager

  Emilie_Headshot_cropped2 (1)

 

Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific. 

 

Five fast lessons from Reuters Pharma USA 2025

At Reuters Pharma USA 2025, industry leaders reinforced the need to put patients first, embrace agility, and simplify treatment access. The Swoop and...

Read More

From Sick Care to Health Care: Transforming Pharma with Data-Driven Insights

Is it possible to truly move from sick care to health care? This year at Reuters Pharma USA, Co-founder and President of MyHealthTeam and Chief...

Read More

Putting the Human Back In Healthcare Marketing

Traditional marketing strategies utilized by retail brands and airlines often don’t work for pharmaceutical manufacturers. Unlike other categories,...

Read More